Orlin Biosciences reached a strategic cooperation agreement with the Jiangsu Provincial Center for Disease Control and Prevention.

On September 8, Chengdu Orlin Biotechnology Co., Ltd. and Jiangsu Provincial Center for Disease Control and Prevention officially signed a strategic cooperation framework agreement in Chengdu. This cooperation focuses on three core areas: vaccine research and development, disease prevention and control, and public health capacity building, aimed at promoting scientific and technological innovation, talent reserves, integration of medical and prevention services, and coordinated development of health services. The key areas include advancing innovative vaccine clinical research and evaluation, optimizing adult vaccination service systems, and upgrading regional infectious disease prevention and control technologies.